|
|
HOT TOPICS IN HYPERTENSION: Issue 8, 2009
New therapeutic progress in cardiorenal protection of the hypertensive patient with a focus on olmesartan
New therapeutic progress in cardiorenal protection of the hypertensive patient with a focus on olmesartan
Vivencio Barrios, Fernando de Alvaro, Rocio Echarri, Carlos Escobar
Correspondence to:
Vivencio Barrios - MD, PhD, FESC Department of Cardiology Universitary Hospital Ramón y Cajal Madrid, Spain E-mail: vbarriosa@meditex.es
Summary
- CARDIORENAL SYNDROME: TWO ORGANS, ONE DISEASE
- THE ROLE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN THE HYPERTENSIVE PATIENT
- THE IMPORTANCE OF BLOOD PRESSURE CONTROL
- THE ROLE OF MODULATION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- OLMESARTAN PLUS HYDROCHLOROTHIAZIDE AND ORGAN PROTECTION
- Olmesartan medoxomil versus other antihypertensive drugs
- Olmesartan medoxomil/hydrochlorothiazide versus other antihypertensive drugs
- Safety of olmesartan medoxomil/hydrochlorothiazide
- PERSPECTIVES AND THE FUTURE OF OLMESARTAN PLUS HYDROCHLOROTHIAZIDE IN CARDIOVASCULAR PROTECTION
- CONCLUSION
- REFERENCES
If you have a Username and Password, you may already access to this article. Please login below.
If you do not have a Username and Password, click the "Register" button below to purchase this article.
|
 |
|
|
|
No additional articles by this author(s) are available in our Series.
|
|
| |
|
|
|